Back

The structural remodeling of the mitochondrial Ca2+ uniporter complex underlies its functional impairment during metabolic cardiomyopathy.

12 April 2024 (15:40 - 16:25)
Organised by: Logo
Congress Presentation Part of: Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy Cardiomyopathies CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Mathieu Panel

Laboratory of Physiology and Experimental Medicine of Heart and Muscles (PhyMedExp), Montpellier (France)

3 More presentations in this session

Presentation thumbnail
Innovative models for cardiotoxicity assessment in human pluripotent stem cell-derived cardiomyocytes that enable clinically relevant treatment regimen
Assistant Professor V. Schwach (Enschede, NL)
Abstract
Presentation thumbnail
Prior cardiac ischemic injury exacerbates immune checkpoint inhibitor-induced cardiotoxicity
Doctor T. Gergely (Budapest, HU)
Abstract
Presentation thumbnail
MicroRNA-mediated control of cardiac fibrosis: unraveling key players and mechanisms through functional genomics screenings
Doctor M. Mano (Coimbra, PT)
Abstract

Access the full session

Session thumbnail
Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April 2024 15:40 CET
You may be interested in
thumbnail
Congress Session
When time is the issue
thumbnail
Congress Session
Genetics in heart failure
thumbnail
Congress Session
When external causes are the villain?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources